A	O
trial	B:C0008976
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	B:C0036983
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	B:C0034656
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	B:C1271494
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	B:C0008976
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	B:C2348563
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	B:C0206035
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	B:C0036983
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	B:C0035273
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	B:C0162791
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	B:C1708333
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	B:C1271494
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	B:C0442123
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	B:C0005889
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	B:C0013227
infusions	O
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	B:C0574032
for	O
persistent	O
and	O
fluid	O
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

A	O
trial	O
to	O
determine	O
whether	O
septic	O
shock	I:C0036983
-	O
reversal	O
is	O
quicker	O
in	O
pediatric	O
patients	O
randomized	O
to	O
an	O
early	O
goal	O
-	I:C1271494
directed	I:C1271494
fluid	I:C1271494
-	I:C1271494
sparing	I:C1271494
strategy	I:C1271494
versus	O
usual	O
care	O
(	O
SQUEEZE	O
)	O
:	O
study	O
protocol	I:C2348563
for	O
a	O
pilot	O
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
Current	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
guidelines	O
from	O
the	O
American	O
College	I:C1708333
of	I:C1708333
Critical	I:C1708333
Care	I:C1708333
Medicine	I:C1708333
focus	O
on	O
the	O
early	O
and	O
goal	O
-	I:C1271494
directed	I:C1271494
administration	I:C1271494
of	O
intravascular	O
fluid	O
followed	O
by	O
vasoactive	O
medication	O
infusions	O
for	O
persistent	O
and	O
fluid	B:C0349412
-	I:C0349412
refractory	I:C0349412
shock	I:C0349412
.	O

However	O
,	O
accumulating	B:C4055506
adult	O
and	O
pediatric	O
data	O
suggest	O
that	O
excessive	O
fluid	O
administration	I:C0522792
is	O
associated	O
with	O
worse	O
patient	O
outcomes	O
and	O
even	O
increased	O
risk	I:C2749787
of	I:C2749787
death	I:C2749787
.	O

However	O
,	O
accumulating	O
adult	O
and	O
pediatric	O
data	O
suggest	O
that	O
excessive	O
fluid	B:C0522792
administration	I:C0522792
is	O
associated	O
with	O
worse	O
patient	O
outcomes	O
and	O
even	O
increased	O
risk	I:C2749787
of	I:C2749787
death	I:C2749787
.	O

However	O
,	O
accumulating	O
adult	O
and	O
pediatric	O
data	O
suggest	O
that	O
excessive	O
fluid	O
administration	I:C0522792
is	O
associated	O
with	O
worse	B:C1457868
patient	O
outcomes	O
and	O
even	O
increased	O
risk	I:C2749787
of	I:C2749787
death	I:C2749787
.	O

However	O
,	O
accumulating	O
adult	O
and	O
pediatric	O
data	O
suggest	O
that	O
excessive	O
fluid	O
administration	I:C0522792
is	O
associated	O
with	O
worse	O
patient	O
outcomes	O
and	O
even	O
increased	B:C2749787
risk	I:C2749787
of	I:C2749787
death	I:C2749787
.	O

The	O
optimal	O
amount	O
of	O
intravascular	B:C0442123
fluid	O
required	O
in	O
early	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
prior	O
to	O
the	O
initiation	O
of	O
vasoactive	O
support	O
remains	O
unanswered	O
.	O

The	O
optimal	O
amount	O
of	O
intravascular	O
fluid	B:C0005889
required	O
in	O
early	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	O
prior	O
to	O
the	O
initiation	O
of	O
vasoactive	O
support	O
remains	O
unanswered	O
.	O

The	O
optimal	O
amount	O
of	O
intravascular	O
fluid	O
required	O
in	O
early	O
pediatric	O
septic	B:C0036983
shock	I:C0036983
resuscitation	O
prior	O
to	O
the	O
initiation	O
of	O
vasoactive	O
support	O
remains	O
unanswered	O
.	O

The	O
optimal	O
amount	O
of	O
intravascular	O
fluid	O
required	O
in	O
early	O
pediatric	O
septic	O
shock	I:C0036983
resuscitation	B:C0035273
prior	O
to	O
the	O
initiation	O
of	O
vasoactive	O
support	O
remains	O
unanswered	O
.	O

The	O
SQUEEZE	B:C0008976
Pilot	I:C0008976
Trial	I:C0008976
is	O
a	O
pragmatic	O
,	O
two	O
-	I:C0242481
arm	I:C0242481
,	O
parallel	O
-	I:C2826345
group	I:C2826345
,	O
open	O
-	I:C1709323
label	I:C1709323
,	O
prospective	O
pilot	I:C0206035
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
.	O

The	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
is	O
a	O
pragmatic	O
,	O
two	B:C0242481
-	I:C0242481
arm	I:C0242481
,	O
parallel	O
-	I:C2826345
group	I:C2826345
,	O
open	O
-	I:C1709323
label	I:C1709323
,	O
prospective	O
pilot	I:C0206035
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
.	O

The	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
is	O
a	O
pragmatic	O
,	O
two	O
-	I:C0242481
arm	I:C0242481
,	O
parallel	B:C2826345
-	I:C2826345
group	I:C2826345
,	O
open	O
-	I:C1709323
label	I:C1709323
,	O
prospective	O
pilot	I:C0206035
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
.	O

The	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
is	O
a	O
pragmatic	O
,	O
two	O
-	I:C0242481
arm	I:C0242481
,	O
parallel	O
-	I:C2826345
group	I:C2826345
,	O
open	B:C1709323
-	I:C1709323
label	I:C1709323
,	O
prospective	O
pilot	I:C0206035
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
.	O

The	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
is	O
a	O
pragmatic	O
,	O
two	O
-	I:C0242481
arm	I:C0242481
,	O
parallel	O
-	I:C2826345
group	I:C2826345
,	O
open	O
-	I:C1709323
label	I:C1709323
,	O
prospective	B:C0206035
pilot	I:C0206035
randomized	I:C0206035
controlled	I:C0206035
trial	I:C0206035
.	O

Participants	B:C0679646
are	O
children	O
aged	O
29	O
days	O
to	O
under	O
18	O
years	O
with	O
suspected	O
or	O
confirmed	O
septic	O
shock	I:C0036983
and	O
a	O
need	O
for	O
ongoing	O
resuscitation	O
.	O

Participants	O
are	O
children	O
aged	O
29	O
days	O
to	O
under	O
18	O
years	O
with	O
suspected	O
or	O
confirmed	B:C0750484
septic	O
shock	I:C0036983
and	O
a	O
need	O
for	O
ongoing	O
resuscitation	O
.	O

Participants	O
are	O
children	O
aged	O
29	O
days	O
to	O
under	O
18	O
years	O
with	O
suspected	O
or	O
confirmed	O
septic	B:C0036983
shock	I:C0036983
and	O
a	O
need	O
for	O
ongoing	O
resuscitation	O
.	O

Participants	O
are	O
children	O
aged	O
29	O
days	O
to	O
under	O
18	O
years	O
with	O
suspected	O
or	O
confirmed	O
septic	O
shock	I:C0036983
and	O
a	O
need	O
for	O
ongoing	O
resuscitation	B:C0035273
.	O

Eligible	O
participants	B:C0679646
are	O
enrolled	O
under	O
an	O
exception	O
to	O
consent	O
process	O
and	O
randomly	O
assigned	O
via	O
concealed	O
allocation	O
to	O
either	O
the	O
Usual	O
Care	O
(	O
control	O
)	O
or	O
Fluid	O
Sparing	I:C0035273
(	I:C0035273
intervention	I:C0035273
)	I:C0035273
resuscitation	I:C0035273
strategy	I:C0035273
.	O

Eligible	O
participants	O
are	O
enrolled	B:C1516879
under	O
an	O
exception	O
to	O
consent	O
process	O
and	O
randomly	O
assigned	O
via	O
concealed	O
allocation	O
to	O
either	O
the	O
Usual	O
Care	O
(	O
control	O
)	O
or	O
Fluid	O
Sparing	I:C0035273
(	I:C0035273
intervention	I:C0035273
)	I:C0035273
resuscitation	I:C0035273
strategy	I:C0035273
.	O

Eligible	O
participants	O
are	O
enrolled	O
under	O
an	O
exception	O
to	O
consent	O
process	O
and	O
randomly	O
assigned	O
via	O
concealed	O
allocation	O
to	O
either	O
the	O
Usual	O
Care	O
(	O
control	O
)	O
or	O
Fluid	B:C0035273
Sparing	I:C0035273
(	I:C0035273
intervention	I:C0035273
)	I:C0035273
resuscitation	I:C0035273
strategy	I:C0035273
.	O

The	O
primary	O
objective	B:C0018017
of	O
this	O
pilot	O
trial	I:C0008976
is	O
to	O
determine	O
feasibility	O
,	O
based	O
on	O
the	O
ability	O
to	O
enroll	O
participants	O
and	O
to	O
adhere	O
to	O
the	O
study	O
protocol	I:C2348563
.	O

The	O
primary	O
objective	O
of	O
this	O
pilot	B:C0008976
trial	I:C0008976
is	O
to	O
determine	O
feasibility	O
,	O
based	O
on	O
the	O
ability	O
to	O
enroll	O
participants	O
and	O
to	O
adhere	O
to	O
the	O
study	O
protocol	I:C2348563
.	O

The	O
primary	O
objective	O
of	O
this	O
pilot	O
trial	I:C0008976
is	O
to	O
determine	O
feasibility	B:C0015730
,	O
based	O
on	O
the	O
ability	O
to	O
enroll	O
participants	O
and	O
to	O
adhere	O
to	O
the	O
study	O
protocol	I:C2348563
.	O

The	O
primary	O
objective	O
of	O
this	O
pilot	O
trial	I:C0008976
is	O
to	O
determine	O
feasibility	O
,	O
based	O
on	O
the	O
ability	O
to	O
enroll	B:C1516879
participants	O
and	O
to	O
adhere	O
to	O
the	O
study	O
protocol	I:C2348563
.	O

The	O
primary	O
objective	O
of	O
this	O
pilot	O
trial	I:C0008976
is	O
to	O
determine	O
feasibility	O
,	O
based	O
on	O
the	O
ability	O
to	O
enroll	O
participants	B:C0679646
and	O
to	O
adhere	O
to	O
the	O
study	O
protocol	I:C2348563
.	O

The	O
primary	O
objective	O
of	O
this	O
pilot	O
trial	I:C0008976
is	O
to	O
determine	O
feasibility	O
,	O
based	O
on	O
the	O
ability	O
to	O
enroll	O
participants	O
and	O
to	O
adhere	O
to	O
the	O
study	B:C2348563
protocol	I:C2348563
.	O

The	O
primary	O
outcome	O
measure	O
by	O
which	O
success	O
will	O
be	O
determined	O
is	O
participant	B:C0679646
enrollment	O
rate	O
(	O
"	O
pass	O
"	O
defined	O
as	O
at	O
least	O
two	O
participants	O
/	O
site	O
/	O
month	O
,	O
recognizing	O
that	O
enrollment	O
may	O
be	O
slower	O
during	O
the	O
run-in	O
phase	O
)	O
.	O

The	O
primary	O
outcome	O
measure	O
by	O
which	O
success	O
will	O
be	O
determined	O
is	O
participant	O
enrollment	B:C1516879
rate	O
(	O
"	O
pass	O
"	O
defined	O
as	O
at	O
least	O
two	O
participants	O
/	O
site	O
/	O
month	O
,	O
recognizing	O
that	O
enrollment	O
may	O
be	O
slower	O
during	O
the	O
run-in	O
phase	O
)	O
.	O

The	O
primary	O
outcome	O
measure	O
by	O
which	O
success	O
will	O
be	O
determined	O
is	O
participant	O
enrollment	O
rate	O
(	O
"	O
pass	O
"	O
defined	O
as	O
at	O
least	O
two	O
participants	B:C0679646
/	O
site	O
/	O
month	O
,	O
recognizing	O
that	O
enrollment	O
may	O
be	O
slower	O
during	O
the	O
run-in	O
phase	O
)	O
.	O

The	O
primary	O
outcome	O
measure	O
by	O
which	O
success	O
will	O
be	O
determined	O
is	O
participant	O
enrollment	O
rate	O
(	O
"	O
pass	O
"	O
defined	O
as	O
at	O
least	O
two	O
participants	O
/	O
site	B:C0205145
/	O
month	O
,	O
recognizing	O
that	O
enrollment	O
may	O
be	O
slower	O
during	O
the	O
run-in	O
phase	O
)	O
.	O

The	O
primary	O
outcome	O
measure	O
by	O
which	O
success	O
will	O
be	O
determined	O
is	O
participant	O
enrollment	O
rate	O
(	O
"	O
pass	O
"	O
defined	O
as	O
at	O
least	O
two	O
participants	O
/	O
site	O
/	O
month	O
,	O
recognizing	O
that	O
enrollment	B:C1516879
may	O
be	O
slower	O
during	O
the	O
run-in	O
phase	O
)	O
.	O

Secondary	O
objectives	B:C0018017
include	O
assessing	O
(	O
1	O
)	O
appropriateness	O
of	O
eligibility	O
criteria	O
,	O
and	O
(	O
2	O
)	O
completeness	O
of	O
clinical	O
outcomes	O
to	O
inform	O
the	O
endpoints	O
for	O
the	O
planned	O
multisite	O
trial	I:C0206012
.	O

Secondary	O
objectives	O
include	O
assessing	O
(	O
1	O
)	O
appropriateness	O
of	O
eligibility	O
criteria	O
,	O
and	O
(	O
2	O
)	O
completeness	O
of	O
clinical	O
outcomes	O
to	O
inform	O
the	O
endpoints	O
for	O
the	O
planned	O
multisite	B:C0206012
trial	I:C0206012
.	O

To	O
support	O
the	O
nested	B:C0008972
translational	I:C0008972
study	I:C0008972
,	O
SQUEEZE	O
-D	I:C0008972
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	O
of	O
describing	O
cell	O
-	I:C4289789
free	I:C4289789
DNA	I:C4289789
(	O
a	O
procoagulant	O
molecule	I:C1292267
with	O
prognostic	O
utility	I:C0220901
)	O
in	O
blood	O
samples	I:C0178913
obtained	O
from	O
children	O
enrolled	O
into	O
the	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O

To	O
support	O
the	O
nested	O
translational	I:C0008972
study	I:C0008972
,	O
SQUEEZE	B:C0008972
-D	I:C0008972
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	O
of	O
describing	O
cell	O
-	I:C4289789
free	I:C4289789
DNA	I:C4289789
(	O
a	O
procoagulant	O
molecule	I:C1292267
with	O
prognostic	O
utility	I:C0220901
)	O
in	O
blood	O
samples	I:C0178913
obtained	O
from	O
children	O
enrolled	O
into	O
the	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O

To	O
support	O
the	O
nested	O
translational	I:C0008972
study	I:C0008972
,	O
SQUEEZE	O
-D	I:C0008972
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	B:C0015730
of	O
describing	O
cell	O
-	I:C4289789
free	I:C4289789
DNA	I:C4289789
(	O
a	O
procoagulant	O
molecule	I:C1292267
with	O
prognostic	O
utility	I:C0220901
)	O
in	O
blood	O
samples	I:C0178913
obtained	O
from	O
children	O
enrolled	O
into	O
the	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O

To	O
support	O
the	O
nested	O
translational	I:C0008972
study	I:C0008972
,	O
SQUEEZE	O
-D	I:C0008972
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	O
of	O
describing	O
cell	B:C4289789
-	I:C4289789
free	I:C4289789
DNA	I:C4289789
(	O
a	O
procoagulant	O
molecule	I:C1292267
with	O
prognostic	O
utility	I:C0220901
)	O
in	O
blood	O
samples	I:C0178913
obtained	O
from	O
children	O
enrolled	O
into	O
the	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O

To	O
support	O
the	O
nested	O
translational	I:C0008972
study	I:C0008972
,	O
SQUEEZE	O
-D	I:C0008972
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	O
of	O
describing	O
cell	O
-	I:C4289789
free	I:C4289789
DNA	I:C4289789
(	O
a	O
procoagulant	B:C1292267
molecule	I:C1292267
with	O
prognostic	O
utility	I:C0220901
)	O
in	O
blood	O
samples	I:C0178913
obtained	O
from	O
children	O
enrolled	O
into	O
the	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O

To	O
support	O
the	O
nested	O
translational	I:C0008972
study	I:C0008972
,	O
SQUEEZE	O
-D	I:C0008972
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	O
of	O
describing	O
cell	O
-	I:C4289789
free	I:C4289789
DNA	I:C4289789
(	O
a	O
procoagulant	O
molecule	I:C1292267
with	O
prognostic	B:C0220901
utility	I:C0220901
)	O
in	O
blood	O
samples	I:C0178913
obtained	O
from	O
children	O
enrolled	O
into	O
the	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O

To	O
support	O
the	O
nested	O
translational	I:C0008972
study	I:C0008972
,	O
SQUEEZE	O
-D	I:C0008972
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	O
of	O
describing	O
cell	O
-	I:C4289789
free	I:C4289789
DNA	I:C4289789
(	O
a	O
procoagulant	O
molecule	I:C1292267
with	O
prognostic	O
utility	I:C0220901
)	O
in	O
blood	B:C0178913
samples	I:C0178913
obtained	O
from	O
children	O
enrolled	O
into	O
the	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O

To	O
support	O
the	O
nested	O
translational	I:C0008972
study	I:C0008972
,	O
SQUEEZE	O
-D	I:C0008972
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	O
of	O
describing	O
cell	O
-	I:C4289789
free	I:C4289789
DNA	I:C4289789
(	O
a	O
procoagulant	O
molecule	I:C1292267
with	O
prognostic	O
utility	I:C0220901
)	O
in	O
blood	O
samples	I:C0178913
obtained	O
from	O
children	O
enrolled	B:C1516879
into	O
the	O
SQUEEZE	O
Pilot	I:C0008976
Trial	I:C0008976
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O

To	O
support	O
the	O
nested	O
translational	I:C0008972
study	I:C0008972
,	O
SQUEEZE	O
-D	I:C0008972
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	O
of	O
describing	O
cell	O
-	I:C4289789
free	I:C4289789
DNA	I:C4289789
(	O
a	O
procoagulant	O
molecule	I:C1292267
with	O
prognostic	O
utility	I:C0220901
)	O
in	O
blood	O
samples	I:C0178913
obtained	O
from	O
children	O
enrolled	O
into	O
the	O
SQUEEZE	B:C0008976
Pilot	I:C0008976
Trial	I:C0008976
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O

The	O
optimal	O
degree	O
of	O
fluid	B:C0005889
resuscitation	O
and	O
the	O
timing	O
of	O
initiation	O
of	O
vasoactive	O
support	O
in	O
order	O
to	O
achieve	O
recommended	O
therapeutic	O
targets	O
in	O
children	O
with	O
septic	O
shock	I:C0036983
remains	O
unanswered	O
.	O

The	O
optimal	O
degree	O
of	O
fluid	O
resuscitation	B:C0035273
and	O
the	O
timing	O
of	O
initiation	O
of	O
vasoactive	O
support	O
in	O
order	O
to	O
achieve	O
recommended	O
therapeutic	O
targets	O
in	O
children	O
with	O
septic	O
shock	I:C0036983
remains	O
unanswered	O
.	O

The	O
optimal	O
degree	O
of	O
fluid	O
resuscitation	O
and	O
the	O
timing	O
of	O
initiation	O
of	O
vasoactive	O
support	O
in	O
order	O
to	O
achieve	O
recommended	O
therapeutic	O
targets	O
in	O
children	O
with	O
septic	B:C0036983
shock	I:C0036983
remains	O
unanswered	O
.	O

No	O
prospective	B:C0033522
study	I:C0033522
to	O
date	O
has	O
examined	O
this	O
important	O
question	O
for	O
children	O
in	O
developed	O
countries	O
including	O
Canada	O
.	O

No	O
prospective	O
study	I:C0033522
to	O
date	O
has	O
examined	O
this	O
important	O
question	B:C1522634
for	O
children	O
in	O
developed	O
countries	O
including	O
Canada	O
.	O

No	O
prospective	O
study	I:C0033522
to	O
date	O
has	O
examined	O
this	O
important	O
question	O
for	O
children	O
in	O
developed	O
countries	O
including	O
Canada	B:C0006823
.	O

Recruitment	O
for	O
the	O
SQUEEZE	B:C0008976
Pilot	I:C0008976
Trial	I:C0008976
opened	O
on	O
6	O
January	O
2014	O
.	O

Findings	B:C0243095
will	O
inform	O
the	O
feasibility	O
of	O
the	O
planned	O
multicenter	O
trial	I:C0206012
to	O
answer	O
our	O
overall	O
research	O
question	O
.	O

Findings	O
will	O
inform	O
the	O
feasibility	B:C0015730
of	O
the	O
planned	O
multicenter	O
trial	I:C0206012
to	O
answer	O
our	O
overall	O
research	O
question	O
.	O

Findings	O
will	O
inform	O
the	O
feasibility	O
of	O
the	O
planned	O
multicenter	B:C0206012
trial	I:C0206012
to	O
answer	O
our	O
overall	O
research	O
question	O
.	O

